IMARC Group, a leading market research company, has recently releases report titled “Intermittent Catheters Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global intermittent catheters market size reached US$ 2.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.
Intermittent catheterization represents the procedure of inserting and extracting a catheter to drain urine from a bladder. It is an effective management strategy for patients with incomplete bladder emptying, owing to inflammation, neurological conditions, pharmacological agents, idiopathic or neurogenic detrusor overactivity (NDO) dysfunction, and physical bladder obstruction. Intermittent catheters are easy to use and convenient while preventing a distended bladder or a urinary tract infection (UTI). They also avoid leaking, blockage, and bladder spasms. As a result, intermittent catheters find widespread applications in hospitals, medical research centers, and ambulatory surgical clinics across the globe.
Request PDF Sample for more detailed market insights: https://www.imarcgroup.com/intermittent-catheters-market/requestsample
Intermittent Catheters Market Trends and Drivers:
The escalating number of patients suffering from urinary tract infections (UTIs) and blockages in the urethra and the rising incidences of tumors in the reproductive organs are among the primary factors driving the intermittent catheters market. Besides this, the increasing prevalence of urological disorders, such as benign prostatic hyperplasia, cystitis, and kidney stones among the masses, is further augmenting the market growth. Moreover, the elevating requirement for intermittent catheters in various medical conditions, including spinal cord injury, multiple sclerosis, or dementia, and the expanding healthcare industry are also catalyzing the global market. Apart from this, the extensive research and development (R&D) activities by the leading players to introduce coated urine catheters with temperature monitoring for enhanced protection against secondary infections are acting as significant growth-inducing factors. Additionally, the inflating need for hydrophilic and antimicrobial product variants is also stimulating the market growth. Furthermore, the launch of platforms to provide online counseling and guidance to patients who cannot visit healthcare facilities for treatment is expected to bolster the intermittent catheters market in the coming years.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Becton Dickinson and Company
- B. Braun Melsungen AG
- Coloplast A/S
- Cure Medical LLC (Convatec Group plc)
- Hollister Incorporated
- Hunter Urology, Medical Technologies of Georgia Inc.
- Pennine Healthcare Ltd.
- Teleflex Inc and Wellspect Limited (Dentsply Sirona).
Key Market Segmentation:
The report has segmented the market on the basis of product, indication, category and end user.
Breakup by Product:
- Uncoated Intermittent Catheter
- Coated Intermittent Catheter
- Antimicrobial
- Hydrophilic
- Others
Breakup by Indication:
- Urinary Incontinence
- Surgery (Major Surgery)
- Spinal Cord Injury
- Others
Breakup by Category:
- Male Length Catheter
- Kids Length Catheter
- Female Length Catheter
Breakup by End User:
- Hospitals
- Medical Research Centers
- Ambulatory Surgical Centers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance
- Market Outlook
- Porter's Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Comments